SLIDE 6 4 ' '
%&& < <
?*"!"" !!!$$!!+ !!!$$!!+ "$ "$
*D(
D "$!!+
9 0(5"1 0(5"1
9"$ 0(5 0(5 "1 "1
($!+L Ebrahim et al. (1997) /*.,33A"++ L
O verall (I-squa red = 61.5%, p = 0.000) Ebrahim, 1997 Barnett, 2003 W o
Luukinen, 2007 Campbe l l, 2005 Schoe nfelder, 2000 Sihvonen , 2004 Lord, 2003 Buchn er, 1997 Author, Nowalk, Tai C hi, 2001 Mulrow , 1994 Day, 200 2 Reinsch, 1992 Skelton, 2005 W o l f, Balance, 1996 W o
W o l f, Tai Chi, 1996 year McMurdo , 1997 Korpelainen, 2 006 Morg an, 2004 Campbe l l, 1999 Hauer, 2001 Vouke l atos, 2 007 Fabe r, Functi o nal walking, 2006 Li , 2 005 Lord, 1995 Schne l le, 200 3 Stei nb erg, 2000 Fabe r, Tai Chi, 2006 Li u-Ambrose , Resistance , 2004 Li n, 2007 Bunout, 2005 Li u-Ambrose , Agility, 2004 Resnick, 2002 Latham, 2003 Madurei ra, 2007 Carter, 2002 G reen, 2002 Toulotte, 2003 W o l f, 2003 Cerny, 1998 Sakamoto, 2006 Rubenstein, 2000 Means, 2005 Protas, 200 6 Suzuki, 2004 Campbe l l, 1997 Nowalk, Re sist./Endurance, 2001 Robertson, 2001 0.83 (0.75, 0.91) 1.29 (0.90, 1.83) 0.60 (0.36, 0.99) 0.49 (0.24, 0.99) 0.93 (0.80, 1.09) 1.15 (0.82, 1.61) 3.06 (1.61, 5.82) 0.38 (0.17, 0.87) 0.78 (0.62, 0.99) 0.61 (0.40, 0.94) Effect 0.77 (0.46, 1.28) 1.26 (0.90, 1.76) 0.82 (0.70, 0.97) 1.24 (0.77, 1.98) 0.69 (0.50, 0.96) 0.98 (0.71, 1.34) 0.78 (0.41, 1.48) 0.51 (0.36, 0.72) size (95% CI) 0.53 (0.28, 0.98) 0.79 (0.59, 1.05) 1.05 (0.66, 1.68) 0.87 (0.36, 2.10) 0.75 (0.46, 1.25) 0.67 (0.46, 0.97) 1.32 (1.03, 1.69) 0.45 (0.33, 0.62) 0.85 (0.57, 1.27) 0.62 (0.38, 1.00) 0.90 (0.79, 1.03) 0.96 (0.76, 1.22) 1.80 (0.67, 4.85) 0.67 (0.32, 1.41) 1.22 (0.70, 2.14) 1.03 (0.36, 2.98) 0.71 (0.04, 11.58) 1.08 (0.87, 1.35) 0.48 (0.25, 0.93) 0.88 (0.32, 2.41) 1.34 (0.87, 2.07) 0.08 (0.00, 1.37) 0.75 (0.52, 1.08) 0.87 (0.17, 4.29) 0.82 (0.64, 1.04) 0.90 (0.42, 1.91) 0.41 (0.21, 0.77) 0.62 (0.26, 1.48) 0.35 (0.14, 0.90) 0.68 (0.52, 0.89) 0.96 (0.63, 1.46) 0.54 (0.32, 0.91) 100.00 2.64 1.88 1.22 3.85 2.74 1.40 0.98 3.38 2.21 % 1.88 2.75 3.80 2.04 2.81 2.86 1.41 2.67 Weight 1.48 3.05 2.04 0.88 1.89 2.56 3.31 2.87 2.38 1.98 3.97 3.34 0.72 1.13 1.67 0.65 0.11 3.46 1.34 0.70 2.21 0.10 2.58 0.31 3.34 1.11 1.40 0.88 0.80 3.13 2.27 1.84 0.83 (0.75, 0.91) 1.29 (0.90, 1.83) 0.60 (0.36, 0.99) 0.49 (0.24, 0.99) 0.93 (0.80, 1.09) 1.15 (0.82, 1.61) 3.06 (1.61, 5.82) 0.38 (0.17, 0.87) 0.78 (0.62, 0.99) 0.61 (0.40, 0.94) Effect 0.77 (0.46, 1.28) 1.26 (0.90, 1.76) 0.82 (0.70, 0.97) 1.24 (0.77, 1.98) 0.69 (0.50, 0.96) 0.98 (0.71, 1.34) 0.78 (0.41, 1.48) 0.51 (0.36, 0.72) size (95% CI) 0.53 (0.28, 0.98) 0.79 (0.59, 1.05) 1.05 (0.66, 1.68) 0.87 (0.36, 2.10) 0.75 (0.46, 1.25) 0.67 (0.46, 0.97) 1.32 (1.03, 1.69) 0.45 (0.33, 0.62) 0.85 (0.57, 1.27) 0.62 (0.38, 1.00) 0.90 (0.79, 1.03) 0.96 (0.76, 1.22) 1.80 (0.67, 4.85) 0.67 (0.32, 1.41) 1.22 (0.70, 2.14) 1.03 (0.36, 2.98) 0.71 (0.04, 11.58) 1.08 (0.87, 1.35) 0.48 (0.25, 0.93) 0.88 (0.32, 2.41) 1.34 (0.87, 2.07) 0.08 (0.00, 1.37) 0.75 (0.52, 1.08) 0.87 (0.17, 4.29) 0.82 (0.64, 1.04) 0.90 (0.42, 1.91) 0.41 (0.21, 0.77) 0.62 (0.26, 1.48) 0.35 (0.14, 0.90) 0.68 (0.52, 0.89) 0.96 (0.63, 1.46) 0.54 (0.32, 0.91) 100.00 2.64 1.88 1.22 3.85 2.74 1.40 0.98 3.38 2.21 % 1.88 2.75 3.80 2.04 2.81 2.86 1.41 2.67 Weight 1.48 3.05 2.04 0.88 1.89 2.56 3.31 2.87 2.38 1.98 3.97 3.34 0.72 1.13 1.67 0.65 0.11 3.46 1.34 0.70 2.21 0.10 2.58 0.31 3.34 1.11 1.40 0.88 0.80 3.13 2.27 1.84 Favours exercise Favours control 1 .25 .5 1 2 4
RR = 0.83
95%CI 0.75-0.91 P<0.001
17% reduction in falls
+) +)
I² = 62% moderate heterogeneity
*&7&4
. "D
. "D & ++"+ ++"+ & $!! $!! & ++ ++ $!!+$!! $!!+$!!
24%
RR 0.76
(95%CI =0.62 to 0.93)
New Zealand RCTs RCTs -
OTAGO
Individually tailored programme: Campbell, BMJ 1997
- 80+ years, n=233, home-based, physiotherapist
- 1 year, falls 32%, injuries 39%
Nurse delivered programme at home: Robertson, BMJ 2001
- 75+ years, n= 240, home-based, district nurse
- 1 year, falls 46%, serious injuries and hospital costs
Nurse programme at GP centres: Robertson, BMJ 2001
- 80+ years, n=450, home-based, general practice nurse
- 1 year, falls 30%, injuries 28%
Visually Impaired Older People: Campbell, BMJ 2005
- 1 year, home-based. Only effective with full compliance, falls 28%
6 month programme: Liu-Ambrose, JAGS 2008
- 70+ years, home-based, cognitive function improvements after 6 months
and after 1 year falls 47%
").& ").& () ()
'+46V;+!$
$! "& $ "$"
02*1
9" & 3)A4 "!! "$!
$+!;
Skelton et al. J.Aging Phys Act 2004; 12 (3); 457-458 & Age and Ageing, 2005: 34: 636-639